Cleared Traditional

K022117 - MAJESTIK (TM) SHIELDED ANGIOGRAPHY NEEDLE, MODEL STAN18T71W-25, MAJESTIK (TM) SHIELDED ANGIOGTAPHY NEEDLE, SRAN18T71WR-5 (FDA 510(k) Clearance)

Oct 2002
Decision
102d
Days
Class 2
Risk

K022117 is an FDA 510(k) clearance for the MAJESTIK (TM) SHIELDED ANGIOGRAPHY NEEDLE, MODEL STAN18T71W-25, MAJESTIK (TM) SHIELDED ANGIOGTAPHY NEEDLE, SRAN18T71WR-5. This device is classified as a Trocar (Class II - Special Controls, product code DRC).

Submitted by Merit Medical Systems, Inc. (South Jordan, US). The FDA issued a Cleared decision on October 11, 2002, 102 days after receiving the submission on July 1, 2002.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1390.

Submission Details

510(k) Number K022117 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 01, 2002
Decision Date October 11, 2002
Days to Decision 102 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DRC — Trocar
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1390